JPWO2019140188A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019140188A5 JPWO2019140188A5 JP2020538841A JP2020538841A JPWO2019140188A5 JP WO2019140188 A5 JPWO2019140188 A5 JP WO2019140188A5 JP 2020538841 A JP2020538841 A JP 2020538841A JP 2020538841 A JP2020538841 A JP 2020538841A JP WO2019140188 A5 JPWO2019140188 A5 JP WO2019140188A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- mmol
- compound
- disease
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023143506A JP2023179445A (ja) | 2018-01-11 | 2023-09-05 | 疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862616253P | 2018-01-11 | 2018-01-11 | |
| US62/616,253 | 2018-01-11 | ||
| PCT/US2019/013193 WO2019140188A1 (fr) | 2018-01-11 | 2019-01-11 | Inhibiteurs de la dihydrocéramide désaturase pour le traitement d'une maladie |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023143506A Division JP2023179445A (ja) | 2018-01-11 | 2023-09-05 | 疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021510818A JP2021510818A (ja) | 2021-04-30 |
| JPWO2019140188A5 true JPWO2019140188A5 (fr) | 2022-01-19 |
| JP7346425B2 JP7346425B2 (ja) | 2023-09-19 |
Family
ID=67219929
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538841A Active JP7346425B2 (ja) | 2018-01-11 | 2019-01-11 | 疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤 |
| JP2023143506A Pending JP2023179445A (ja) | 2018-01-11 | 2023-09-05 | 疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023143506A Pending JP2023179445A (ja) | 2018-01-11 | 2023-09-05 | 疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11597715B2 (fr) |
| EP (1) | EP3737361A4 (fr) |
| JP (2) | JP7346425B2 (fr) |
| KR (1) | KR20200119807A (fr) |
| CN (1) | CN111787916B (fr) |
| AU (1) | AU2019207887B2 (fr) |
| CA (1) | CA3087729A1 (fr) |
| WO (1) | WO2019140188A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3529245A4 (fr) | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | Composés et utilisations de ces derniers |
| US11135207B2 (en) * | 2016-12-13 | 2021-10-05 | Centaurus Therapeutics | Inhibitors of dihydroceramide desaturase for treating disease |
| CA3083000A1 (fr) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Composes et utilisations de ces composes |
| WO2022115612A1 (fr) * | 2020-11-25 | 2022-06-02 | Lysosomal and Rare Disorders Research and Treatment Center, Inc. | Inhibition de voie de caspase en tant que traitement pour des troubles du stockage lysosomal |
| TW202321224A (zh) * | 2021-07-29 | 2023-06-01 | 大陸商上海齊魯製藥研究中心有限公司 | 新型parp7抑制劑及其應用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62249945A (ja) * | 1986-04-23 | 1987-10-30 | Fuji Photo Film Co Ltd | ハイドロキノン・モノエステル類の合成方法 |
| EP0968200A1 (fr) | 1997-02-24 | 2000-01-05 | ZymoGenetics, Inc. | Mimetiques de calcitonine |
| FR2770131A1 (fr) | 1997-10-27 | 1999-04-30 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
| US6375957B1 (en) * | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
| US6894063B2 (en) | 2000-09-14 | 2005-05-17 | Schering Corporation | Substituted urea neuropeptide Y Y5 Receptor antagonists |
| ES2170030B1 (es) * | 2000-12-19 | 2003-11-16 | Consejo Superior Investigacion | Inhibidores de la dihidroceramida desaturasa. |
| MXPA04000707A (es) | 2001-07-26 | 2004-04-20 | Schering Corp | Nuevos antagonistas del receptor y5 del neuropeptido y referencia cruzada a solicitudes relacionadas. |
| BRPI0410657A (pt) | 2003-06-12 | 2006-06-20 | Novo Nordisk As | composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto |
| EP1636187A1 (fr) | 2003-06-12 | 2006-03-22 | Novo Nordisk A/S | Carbamates de piperazine a substitution utilises en tant qu'inhibiteurs de la lipase hormonosensible |
| US7129235B2 (en) | 2003-07-11 | 2006-10-31 | Abbott Laboratories | Amides useful for treating pain |
| WO2005014580A1 (fr) | 2003-08-08 | 2005-02-17 | Janssen Pharmaceutica, N.V. | Urees pyridyle piperazinyle |
| US7491720B2 (en) | 2004-10-29 | 2009-02-17 | Banyu Pharmaceutical Co., Ltd. | Aminopyridine derivatives having Aurora A selective inhibitory action |
| TW200633990A (en) | 2004-11-18 | 2006-10-01 | Takeda Pharmaceuticals Co | Amide compound |
| MX2007006178A (es) | 2004-11-23 | 2007-06-20 | Ptc Therapeutics Inc | Fenoles substituidos como agentes activos que inhiben la produccion del factor de crecimiento endotelial vascular. |
| WO2006074025A1 (fr) | 2004-12-30 | 2006-07-13 | Janssen Pharmaceutica N.V. | Urees piperazinyle et piperidinyle en tant que modulateurs de l’amide hydrolase d’acides gras |
| US7790726B2 (en) | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
| WO2007149865A2 (fr) | 2006-06-19 | 2007-12-27 | University Of Utah Research Foundation | Procédés et compositions liés à l'inhibition de la synthèse de la céramide |
| CA2665804A1 (fr) | 2006-08-23 | 2008-02-28 | Astellas Pharma Inc. | Compose d'uree ou sel dudit compose |
| BRPI0821871A2 (pt) * | 2008-01-03 | 2015-06-16 | Wockhardt Research Center | Suspensão farmacêutica oral compreendendo paracetamol e ibuprofeno |
| WO2010023512A1 (fr) * | 2008-08-28 | 2010-03-04 | Matrix Laboratories Ltd. | Nouveaux modulateurs de récepteur vanilloïde, procédé pour leur préparation et compositions pharmaceutiques contenant ceux-ci |
| FR2939135B1 (fr) * | 2008-12-02 | 2010-12-03 | Galderma Res & Dev | Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| WO2010088392A1 (fr) | 2009-01-28 | 2010-08-05 | Rigel Pharmaceuticals, Inc. | Composés carboxamides et leurs procédés d'utilisation |
| JP2010195688A (ja) | 2009-02-23 | 2010-09-09 | Shionogi & Co Ltd | Ｎｐｙｙ５受容体拮抗作用を有するアミド及びウレア誘導体 |
| CA2785284A1 (fr) | 2009-12-25 | 2011-06-30 | Tomoyuki Kamino | Nouveau derive aryl-uree |
| CN103172635B (zh) * | 2011-12-21 | 2016-04-27 | 上海医药工业研究院 | 哌嗪或哌啶类化合物、其盐、中间体、制备方法及应用 |
| WO2015038704A1 (fr) * | 2013-09-11 | 2015-03-19 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Compositions pour prépaprer des cardiomyocytes |
| TW201806939A (zh) * | 2016-06-30 | 2018-03-01 | 巴塞利亞藥業國際股份有限公司 | 用於治療增生性障礙之線粒體抑制劑 |
| US11135207B2 (en) * | 2016-12-13 | 2021-10-05 | Centaurus Therapeutics | Inhibitors of dihydroceramide desaturase for treating disease |
-
2019
- 2019-01-11 CA CA3087729A patent/CA3087729A1/fr active Pending
- 2019-01-11 US US16/959,807 patent/US11597715B2/en active Active
- 2019-01-11 EP EP19738156.9A patent/EP3737361A4/fr active Pending
- 2019-01-11 WO PCT/US2019/013193 patent/WO2019140188A1/fr unknown
- 2019-01-11 KR KR1020207023098A patent/KR20200119807A/ko not_active Application Discontinuation
- 2019-01-11 AU AU2019207887A patent/AU2019207887B2/en active Active
- 2019-01-11 JP JP2020538841A patent/JP7346425B2/ja active Active
- 2019-01-11 CN CN201980015846.3A patent/CN111787916B/zh active Active
-
2023
- 2023-02-06 US US18/106,305 patent/US20230357187A1/en active Pending
- 2023-09-05 JP JP2023143506A patent/JP2023179445A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11771684B2 (en) | Inhibitors of dihydroceramide desaturase for treating disease | |
| JP7057798B2 (ja) | ｍＴＯＲＣ１阻害剤 | |
| CN105308036B (zh) | 用于激酶调节的化合物和方法及其适应症 | |
| JP7346425B2 (ja) | 疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤 | |
| US20190389867A1 (en) | Substituted heterocyclic inhibitors of ptpn11 | |
| JP2021502364A (ja) | 新規なスルホンアミドカルボキサミド化合物 | |
| AU2016324483B2 (en) | Methods and compositions of inhibiting DCN1-UBC12 interaction | |
| KR20170036698A (ko) | 항증식성 화합물 및 이의 사용 방법 | |
| KR20210076910A (ko) | 파르네소이드 x 수용체 효능제 및 그의 용도 | |
| BR112019011825A2 (pt) | composto, enantiômero isolado, composição farmacêutica, método para inibir a atividade do transportador de monocarboxilato mct4, ou um mutante do mesmo, em uma amostra biológica, método para inibir a atividade do transportador de monocarboxilato mct4, ou um mutante do mesmo, em relação ao transportador de monocarboxilato mct1, ou um mutante do mesmo, em um paciente, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 em um sujeito que necessite do mesmo, uso de um composto e método para obter um efeito em um paciente | |
| KR20180128937A (ko) | 질환을 치료하는데 유용한 fimh의 만노스-유래 길항제 | |
| BR112021000395A2 (pt) | Compostos imunomoduladores diméricos contra mecanismos baseados em cereblon | |
| JP2021519308A (ja) | 転写活性化タンパク質のイミダゾピペラジン阻害剤 | |
| AU2012344015A1 (en) | Novel 2H-indazoles as EP2 receptor antagonists | |
| AU2015317886A1 (en) | Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists | |
| CA3182276A1 (fr) | Inhibiteurs de la nek7 kinase | |
| JP2019502663A (ja) | （ｒ）−１−（４−（６−（２−（４−（３，３−ジフルオロシクロブトキシ）−６−メチルピリジン−２−イル）アセトアミド）ピリダジン−３−イル）−２−フルオロブチル）−ｎ−メチル−１ｈ−１，２，３−トリアゾール−４−カルボキサミドの塩形態および多形体 | |
| JP6513075B2 (ja) | オートタキシン阻害活性を有する縮合ピラゾール誘導体 | |
| WO2021045159A1 (fr) | Procédé thérapeutique ou prophylactique pour le diabète utilisant la polythérapie | |
| JPWO2019140188A5 (fr) | ||
| WO2021045161A1 (fr) | Procédé de traitement ou de prévention des insuffisances rénales chroniques | |
| KR20220132538A (ko) | 디하이드로오로테이트 데하이드로게나제를 억제하는 방법 및 조성물 | |
| JP6535007B2 (ja) | 新規ピペリジンカルボキサミド化合物、その調製方法及び使用 | |
| WO2023030170A1 (fr) | Composé de dégradation protéique à base de protéine cible nampt et son utilisation | |
| RU2788628C2 (ru) | Ингибиторы активин-рецептороподобной киназы |